SCHEMBL29624972

SCHEMBL29624972

CCNc1cc(F)ccc1N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.53
ALDH1A1 P00352 2/20 0.45
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
THRB P10828 1/20 0.42
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
GFER P55789 1/20 0.42
PLEC Q15149 1/20 0.42
HDAC1 Q13547 8/20 0.42
KEAP1 Q14145 1/20 0.37
HDAC2 Q92769 5/20 0.37
HDAC3 O15379 1/20 0.37
CYP3A4 P08684 1/20 0.36
TSHR P16473 1/20 0.36
RECQL P46063 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.34
KCNQ3 O43525 1/20 0.33
KCNQ2 O43526 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20345719 1.00 LMNA (0.53) LMNAALDH1A1MAPTKDM4EGAA
SCHEMBL3631150 0.85 ALDH1A1 (0.42) LMNAALDH1A1HDAC1KEAP1HDAC2
SCHEMBL4081482 0.84 ALDH1A1 (0.54) LMNAALDH1A1MAPTKDM4EGAA
SCHEMBL30829688 0.84 ALDH1A1 (0.54) LMNAALDH1A1MAPTKDM4EGAA
SCHEMBL3085200 0.79 MAPT (0.46) LMNAALDH1A1MAPTHTTCYP3A4
SCHEMBL8522276 0.79 LMNA (0.51) LMNAALDH1A1MAPTKDM4EGAA
SCHEMBL22112765 0.79 LMNA (0.51) LMNAALDH1A1MAPTKDM4EGAA
SCHEMBL17845346 0.78 ALDH1A1 (0.43) LMNAALDH1A1HDAC1KEAP1HDAC2
SCHEMBL30532037 0.78 ALDH1A1 (0.43) LMNAALDH1A1HDAC1KEAP1HDAC2
SCHEMBL1643707 0.78 CYP3A4 (0.60) LMNAALDH1A1MAPTKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3562306-B1 METALLOENZYME INHIBITOR COMPOUNDS JI XING PHARMACEUTICALS HONG KONG LTD (HK) 2025-02-26 EP disclosed
CN-112979631-B PARG inhibiting compounds 癌症研究科技有限公司 2024-09-20 CN disclosed
US-11919883-B2 Metalloenzyme inhibitor compounds JI XING PHARMACEUTICALS HONG KONG LIMITED (HK) 2024-03-05 US disclosed
CN-110214141-B Benzodiazolium compounds as ENaC inhibitors 企业治疗学有限公司 2022-05-31 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11919883-B2 Metalloenzyme inhibitor compounds SOD1, RNASE1, FECH LMNA 4166/4885ALDH1A1 457/4885MAPT 2388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.